期刊文献+

心房颤动患者血浆高密度脂蛋白胆固醇水平变化的临床研究 被引量:3

Clinical study on the plasma levels of high density lipoprotein cholesterol in patients with atrial fibrillation
下载PDF
导出
摘要 目的探讨血浆高密度脂蛋白胆固醇(HDL-C)水平与心房颤动之间的关系。方法研究对象为135例房颤患者,按能否自行复律分为阵发性房颤组及非阵发性房颤组,并选择同期健康人群30例作为对照组。非阵发性房颤组又分别按左心房内径(LAD>35mm,LAD≤35mm)分成亚组,测量所有房颤及正常对照组患者的血浆HDL-C的水平,并对其结果进行统计学分析。结果 (1)阵发性房颤组和非阵发性房颤组的HDL-C水平明显低于正常对照组(P<0.01);(2)非阵发性房颤组中LAD>35mm者HDL-C水平明显低于LAD≤35mm(P<0.01);(3)HDL-C浓度与LAD大小成负相关(r=-0.79,P<0.01)。结论证实HDL-C与房颤有关,血浆HDL-C水平降低可能是房颤的诱发因素之一,并参与了房颤的发展过程。 Objective To investigate the relationship between plasma levels of high density lipoprotein cholesterol (HDL-C) and atrial fibrillation (AF). Methods A total of 135 patients with AF were divided into two groups according to spontaneously termination: paroxysmal AF group (n=63) and non-paroxysmal AF group (n=72). Thirty healthy individuals were selected as the control group. Patients in the non-paroxysmal AF group were further divided into two subgroups according to left atrial diameter (LAD): patients with LAD35 mm and patients with LAD≤35 mm. The plasma levels of HDL-C in the three groups were measured and statistically analyzed by SPSS software. Results The plasma levels of HDL-C in the paroxysmal AF group and non-paroxysmal AF group were significantly lower than that in the control group (P0.01). The plasma levels of HDL-C in the patients with LAD35 mm were significantly lower than that in the patients with LAD≤35 mm (P0.01). The plasma levels of HDL-C was negatively correlated with LAD size (r=-0.79, P0.01). Conclusion AF was correlated to the plasma level of HDL-C. The lowering of plasma HDL-C levels may be one of the induction factors for AF, which may promote the progression of AF.
出处 《海南医学》 CAS 2011年第22期4-6,共3页 Hainan Medical Journal
关键词 高密度脂蛋白胆固醇 心房颤动 左房内径 High density lipoprotein cholesterol (HDL-C) Atrial fibrillation Left atrium Diameter (LAD)
  • 相关文献

参考文献15

  • 1Annoura M, Ogawa M, Kumagai K, et al. Cholesterol paradox in pa- tients with paroxysmal atrial fibrillation [J]. Cardiology, 1999, 92: 21-27.
  • 2Engelmann MD, Svendsen JH Inflammation in the genesis and per-petuation of atrial fibrillation [J]. European Heart Journal, 2005, 26: 2083-2092.
  • 3Bruins P, Velthuis H, Yazdanbakhsh AP, et al. Activation of the com- plement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia [J]. Circulation, 1997, 96: 3542-3548.
  • 4Matin F, Corral J, Roldan V, et al. Factor XIII Va134Leu polymor- phism modulates the proothrombotic and inflammatory state associ- ated with atrial fibrillation [J]. J Mol Cell Cardio, 2004, 37(3): 699-704.
  • 5Tveit A, Seljeflot I, Grundvoid I, et al. Effect of candesartanand vari- ous inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation [J]. Am J Cardiol, 2007, 99(11): 1544-1548.
  • 6Acevedo M, Cohalan RL, Perez L, et al. C-reactive protein in at-rial fibrillation: evidence for the presence of inflammation in the gene-sis and perpetuation of the arrhythrnis [J]. Am Coll Cardiol, 2003, 41: 1089.
  • 7Watanabe T, Takeisbi Y, Hlrono O, et al. C-reactive protein eleva- tion predicts the occurrence of atrial structural remodeling in pa- tients with paroxysmal alrial fibrillation [J]. Heart Vessels, 2005, 20 (2): 45-49.
  • 8Verheule S, Wilson E, Everett IV, et al. Alterations in atrial electro- physiology and tissue structure in a canine model of chronic atrial dilatation due to mitml regurgitation [J]. Circulation, 2003, 107: 2615-2622.
  • 9Kamiyama N. Expression of cell adhesion molecules and the appear- ance of adherent leukocytes on the left atrial endothelium with atrial fibrilla-tion: rabbit experimental model [J]. Jpn Circ J, 1998, 62: 837-843.
  • 10Oda MN, Bielicki JK, Ho TT, et al. Paraoxonase 1 overexpression in mice and its effect on high-density lipopmteins [J]. Bioche Bio- phys Reseommun, 2002, 290(3): 921-927.

同被引文献25

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 2Young C E, Karas R H, Kuvin J T. High-density lipoprotein cholesterol and coronary heart disease[J]. Cardiol Rev, 2004,12(2): 107.
  • 3Suzuki S. "Cholesterol paradox" in atrial fibrillation[J]. Circ J, 2011, 75(12):2749.
  • 4Annoura M, Ogawa M, Kumagai K, et al. Cholesterol paradox in patients with paroxysmal atrial fibrillation[J]. Cardiology, 1999,92(1): 21.
  • 5Iguchi Y, Kimura K, Aoki J, et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city [J]. Circ J, 2008,72(6):909.
  • 6Jang M J, Choi W I, Bang S M, et al. Metabolic syndrome is associated with venous thromboembolism in the Korean population ]J]. Arterioscler Thronfl3 Vasc Biol, 2009,29(3):311.
  • 7Kamphuisen P, Becattim C, Brighton T A, et al. Cardiovascular risk factors and venous thromboembolism: A meta-analysis[J]. Circulation, 2007,116(16, S):819.
  • 8Camm A J, Kirchhof P, Lip G Y, et al. Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)[J]. Europace, 2010,12(10):1360.
  • 9Chugh S S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation a global burden of disease 2010 study[J]. Circulation, 2014,129(8):837.
  • 10Fang M C, Go A S, Chang Y, et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation[J]. J Am Coll Cardiol, 2008,51(8):810.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部